Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

Trial Profile

The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dienogest (Primary) ; Norethisterone
  • Indications Endometriosis
  • Focus Therapeutic Use
  • Acronyms DINE

Most Recent Events

  • 01 Jun 2025 Results(n=70) suggesting NETA 5 mg/day may be a better approach instead of dienogest for the endometriosis treatment were published in the European Journal of Obstetrics and Gynecology and Reproductive Biology
  • 20 Jul 2023 Status has been changed to completed.
  • 25 Feb 2023 Planned primary completion date changed from 30 Nov 2022 to 30 Mar 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top